Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Lilly, J&J launches top Clarivate's Drugs to Watch 2026 report
Two investigational cardiometabolic drugs from Eli Lilly stand out in Clarivate's annual Drugs to Watch report. J&J also has two drugs on the list.
Kevin Dunleavy
Jan 7, 2026 9:28am
Lilly touts Zepbound-Taltz combo in patients with obesity, PsA
Jan 8, 2026 2:00pm
FDA rejects Vanda's Hetlioz for a 2nd time in jet lag disorder
Jan 8, 2026 11:20am
InflaRx charts layoffs, cost cuts to lift lead asset's prospects
Jan 8, 2026 11:03am
AZ taps Spain head Rick Suarez to lead US investment surge
Jan 8, 2026 10:40am
Fierce Healthcare
Appeals court affirms temporary pause on 340B rebate pilot
Jan 8, 2026 10:00am
More News
Inside the turning tides of the US biosimilar market
Jan 8, 2026 9:00am
Novo conducts weight stigma conversation at NYC commuter hub
Jan 8, 2026 7:30am
Fierce Biotech
Study finds HIV can evolve to resist lenacapavir—at a cost
Jan 7, 2026 2:00pm
FDA untitled letter skewers Esperion's Nexlizet TV ad
Jan 7, 2026 12:00pm